Yang Conor Chia-hung 3 Filing

From the Filing

EDGAR Filing Documents for 0001193125-26-135600 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 3 - Initial statement of beneficial ownership of securities: SEC Accession No. 0001193125-26-135600 Filing Date 2026-04-01 Accepted 2026-04-01 06:11:10 Documents 2 Period of Report 2026-03-18 Document Format Files Seq Description Document Type Size 1 3 ownership.html 3 1 3 ownership.xml 3 4649 2 EX-24.1 ck0001778016-ex24_1.htm EX-24.1 21958 Complete submission text file 0001193125-26-135600.txt 28257 Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800 NovaBridge Biosciences ( Issuer ) CIK : 0001778016 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address EHANG FUTURE CITY (GROUP HEADQUARTERS) NO. 118 DONGJIANG AVE., HUANGPU DISTRICT GUANGZHOU CITY GUANGDONG PROVINCE China 510730 Business Address Yang Conor Chia-hung ( Reporting ) CIK : 0002121924 (see all company filings) Type: 3 | Act: 34 | File No.: 001-39173 | Film No.: 26824556